Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: LRP5

Gene summary for LRP5

Gene summary.

Gene information	Species	Human
	Gene symbol	LRP5
	Gene ID	4041
	Gene name	LDL receptor related protein 5
	Gene Alias	BMND1
	Cytomap	11q13.2
	Gene Type	protein-coding
	GO ID	GO:0000278
	UniProtAcc	O75197

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
4041	LRP5	HTA11_3410_2000001011	Human	Colorectum	AD	4.25e-02	2.23e-01	0.0155
4041	LRP5	HTA11_2487_2000001011	Human	Colorectum	SER	3.19e-02	3.05e-01	-0.1808
4041	LRP5	HTA11_1938_2000001011	Human	Colorectum	AD	1.46e-04	4.35e-01	-0.0811
4041	LRP5	HTA11_78_2000001011	Human	Colorectum	AD	1.61e-03	3.07e-01	-0.1088
4041	LRP5	HTA11_347_2000001011	Human	Colorectum	AD	1.61e-12	5.14e-01	-0.1954
4041	LRP5	HTA11_83_2000001011	Human	Colorectum	SER	9.33e-05	5.17e-01	-0.1526
4041	LRP5	HTA11_696_2000001011	Human	Colorectum	AD	4.01e-14	6.69e-01	-0.1464
4041	LRP5	HTA11_866_2000001011	Human	Colorectum	AD	1.75e-04	4.27e-01	-0.1001
4041	LRP5	HTA11_1391_2000001011	Human	Colorectum	AD	1.13e-13	7.54e-01	-0.059
4041	LRP5	HTA11_546_2000001011	Human	Colorectum	AD	2.07e-04	5.25e-01	-0.0842
4041	LRP5	HTA11_866_3004761011	Human	Colorectum	AD	1.44e-02	2.88e-01	0.096
4041	LRP5	HTA11_7696_3000711011	Human	Colorectum	AD	6.19e-03	4.54e-01	0.0674
4041	LRP5	HTA11_6818_2000001011	Human	Colorectum	AD	1.32e-02	5.17e-01	0.0112
4041	LRP5	HTA11_6818_2000001021	Human	Colorectum	AD	4.22e-03	4.01e-01	0.0588
4041	LRP5	HTA11_99999971662_82457	Human	Colorectum	MSS	2.36e-02	5.05e-01	0.3859
4041	LRP5	HTA11_99999973899_84307	Human	Colorectum	MSS	1.63e-07	7.44e-01	0.2585
4041	LRP5	A015-C-203	Human	Colorectum	FAP	3.77e-14	-1.75e-01	-0.1294
4041	LRP5	A002-C-201	Human	Colorectum	FAP	3.94e-03	-2.04e-02	0.0324
4041	LRP5	A001-C-108	Human	Colorectum	FAP	1.00e-06	7.70e-02	-0.0272
4041	LRP5	A002-C-205	Human	Colorectum	FAP	1.85e-09	-5.00e-02	-0.1236

Page: 1 2 3 4 5 6

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:0048732	Colorectum	AD	gland development	149/3918	436/18723	6.07e-11	6.33e-09	149
GO:0009743	Colorectum	AD	response to carbohydrate	86/3918	253/18723	8.43e-07	2.90e-05	86
GO:0044282	Colorectum	AD	small molecule catabolic process	118/3918	376/18723	1.05e-06	3.55e-05	118
GO:0030879	Colorectum	AD	mammary gland development	53/3918	137/18723	1.46e-06	4.58e-05	53
GO:0043434	Colorectum	AD	response to peptide hormone	126/3918	414/18723	2.70e-06	7.86e-05	126
GO:0034284	Colorectum	AD	response to monosaccharide	76/3918	225/18723	4.64e-06	1.23e-04	76
GO:0016052	Colorectum	AD	carbohydrate catabolic process	56/3918	154/18723	7.01e-06	1.73e-04	56
GO:0033500	Colorectum	AD	carbohydrate homeostasis	84/3918	259/18723	9.10e-06	2.15e-04	84
GO:0009746	Colorectum	AD	response to hexose	73/3918	219/18723	1.20e-05	2.65e-04	73
GO:0010563	Colorectum	AD	negative regulation of phosphorus metabolic process	130/3918	442/18723	1.26e-05	2.76e-04	130
GO:0009749	Colorectum	AD	response to glucose	71/3918	212/18723	1.31e-05	2.85e-04	71
GO:0042593	Colorectum	AD	glucose homeostasis	83/3918	258/18723	1.44e-05	3.11e-04	83
GO:0001678	Colorectum	AD	cellular glucose homeostasis	60/3918	172/18723	1.49e-05	3.18e-04	60
GO:0016055	Colorectum	AD	Wnt signaling pathway	130/3918	444/18723	1.60e-05	3.37e-04	130
GO:0045936	Colorectum	AD	negative regulation of phosphate metabolic process	129/3918	441/18723	1.81e-05	3.76e-04	129
GO:0019318	Colorectum	AD	hexose metabolic process	77/3918	237/18723	1.96e-05	4.01e-04	77
GO:0198738	Colorectum	AD	cell-cell signaling by wnt	130/3918	446/18723	2.02e-05	4.10e-04	130
GO:0051348	Colorectum	AD	negative regulation of transferase activity	85/3918	268/18723	2.07e-05	4.19e-04	85
GO:0001667	Colorectum	AD	ameboidal-type cell migration	137/3918	475/18723	2.17e-05	4.33e-04	137
GO:0006066	Colorectum	AD	alcohol metabolic process	106/3918	353/18723	3.02e-05	5.57e-04	106

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Enriched KEGG pathways.

Pathway ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	qvalue	Count
hsa05010	Colorectum	AD	Alzheimer disease	174/2092	384/8465	1.82e-19	9.26e-18	5.91e-18	174
hsa05022	Colorectum	AD	Pathways of neurodegeneration - multiple diseases	201/2092	476/8465	4.54e-18	1.27e-16	8.09e-17	201
hsa05225	Colorectum	AD	Hepatocellular carcinoma	59/2092	168/8465	1.50e-03	8.69e-03	5.54e-03	59
hsa04928	Colorectum	AD	Parathyroid hormone synthesis, secretion and action	38/2092	106/8465	6.60e-03	2.77e-02	1.76e-02	38
hsa04310	Colorectum	AD	Wnt signaling pathway	56/2092	171/8465	1.03e-02	3.93e-02	2.51e-02	56
hsa050101	Colorectum	AD	Alzheimer disease	174/2092	384/8465	1.82e-19	9.26e-18	5.91e-18	174
hsa050221	Colorectum	AD	Pathways of neurodegeneration - multiple diseases	201/2092	476/8465	4.54e-18	1.27e-16	8.09e-17	201
hsa052251	Colorectum	AD	Hepatocellular carcinoma	59/2092	168/8465	1.50e-03	8.69e-03	5.54e-03	59
hsa049281	Colorectum	AD	Parathyroid hormone synthesis, secretion and action	38/2092	106/8465	6.60e-03	2.77e-02	1.76e-02	38
hsa043101	Colorectum	AD	Wnt signaling pathway	56/2092	171/8465	1.03e-02	3.93e-02	2.51e-02	56
hsa050102	Colorectum	SER	Alzheimer disease	146/1580	384/8465	6.52e-20	2.40e-18	1.75e-18	146
hsa050222	Colorectum	SER	Pathways of neurodegeneration - multiple diseases	168/1580	476/8465	6.23e-19	2.07e-17	1.50e-17	168
hsa049282	Colorectum	SER	Parathyroid hormone synthesis, secretion and action	31/1580	106/8465	5.20e-03	3.28e-02	2.38e-02	31
hsa050103	Colorectum	SER	Alzheimer disease	146/1580	384/8465	6.52e-20	2.40e-18	1.75e-18	146
hsa050223	Colorectum	SER	Pathways of neurodegeneration - multiple diseases	168/1580	476/8465	6.23e-19	2.07e-17	1.50e-17	168
hsa049283	Colorectum	SER	Parathyroid hormone synthesis, secretion and action	31/1580	106/8465	5.20e-03	3.28e-02	2.38e-02	31
hsa050104	Colorectum	MSS	Alzheimer disease	169/1875	384/8465	1.21e-22	1.01e-20	6.21e-21	169
hsa050224	Colorectum	MSS	Pathways of neurodegeneration - multiple diseases	192/1875	476/8465	2.79e-20	1.04e-18	6.36e-19	192
hsa052252	Colorectum	MSS	Hepatocellular carcinoma	56/1875	168/8465	5.04e-04	3.45e-03	2.11e-03	56
hsa049284	Colorectum	MSS	Parathyroid hormone synthesis, secretion and action	37/1875	106/8465	1.72e-03	9.13e-03	5.59e-03	37

Page: 1 2 3 4

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand	Receptor	LRpair	Pathway	Tissue	Disease Stage
WNT7B	FZD4_LRP5	WNT7B_FZD4_LRP5	WNT	Cervix	ADJ
WNT7B	FZD6_LRP5	WNT7B_FZD6_LRP5	WNT	Cervix	ADJ
WNT2B	FZD6_LRP5	WNT2B_FZD6_LRP5	WNT	Cervix	CC
WNT9A	FZD6_LRP5	WNT9A_FZD6_LRP5	WNT	Cervix	CC
WNT4	FZD5_LRP5	WNT4_FZD5_LRP5	WNT	CRC	AD
WNT2	FZD6_LRP5	WNT2_FZD6_LRP5	WNT	Endometrium	ADJ
WNT4	FZD6_LRP5	WNT4_FZD6_LRP5	WNT	Endometrium	ADJ
WNT10A	FZD4_LRP5	WNT10A_FZD4_LRP5	WNT	HNSCC	OSCC
WNT10A	FZD6_LRP5	WNT10A_FZD6_LRP5	WNT	HNSCC	OSCC
WNT2	FZD4_LRP5	WNT2_FZD4_LRP5	WNT	HNSCC	OSCC
WNT2	FZD6_LRP5	WNT2_FZD6_LRP5	WNT	HNSCC	OSCC
WNT4	FZD4_LRP5	WNT4_FZD4_LRP5	WNT	HNSCC	OSCC
WNT4	FZD6_LRP5	WNT4_FZD6_LRP5	WNT	HNSCC	OSCC
WNT7B	FZD4_LRP5	WNT7B_FZD4_LRP5	WNT	HNSCC	OSCC
WNT7B	FZD6_LRP5	WNT7B_FZD6_LRP5	WNT	HNSCC	OSCC
WNT10A	FZD6_LRP5	WNT10A_FZD6_LRP5	WNT	HNSCC	Precancer
WNT2	FZD6_LRP5	WNT2_FZD6_LRP5	WNT	HNSCC	Precancer
WNT2B	FZD6_LRP5	WNT2B_FZD6_LRP5	WNT	HNSCC	Precancer
WNT4	FZD6_LRP5	WNT4_FZD6_LRP5	WNT	HNSCC	Precancer
WNT7B	FZD6_LRP5	WNT7B_FZD6_LRP5	WNT	HNSCC	Precancer

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

LRP5

SNV

Missense_Mutation

rs750390421

c.2600N>A

p.Ser867Asn

p.S867N

O75197

protein_coding

deleterious(0.05)

probably_damaging(0.985)

TCGA-A1-A0SO-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Chemotherapy

LRP5

SNV

Missense_Mutation

novel

c.1730G>A

p.Ser577Asn

p.S577N

O75197

protein_coding

tolerated(0.6)

benign(0)

TCGA-A8-A07G-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Chemotherapy

5-fluorouracil

LRP5

SNV

Missense_Mutation

novel

c.139G>A

p.Asp47Asn

p.D47N

O75197

protein_coding

tolerated(0.58)

benign(0.36)

TCGA-AC-A23H-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

LRP5

SNV

Missense_Mutation

c.326C>T

p.Ser109Phe

p.S109F

O75197

protein_coding

deleterious(0)

probably_damaging(0.997)

TCGA-AC-A23H-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

LRP5

SNV

Missense_Mutation

rs751683687

c.1117N>T

p.Arg373Trp

p.R373W

O75197

protein_coding

deleterious(0)

probably_damaging(0.982)

TCGA-AN-A0FN-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unknown

LRP5

SNV

Missense_Mutation

novel

c.1752G>C

p.Gln584His

p.Q584H

O75197

protein_coding

deleterious(0)

probably_damaging(0.971)

TCGA-BH-A0C0-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

carboplatin

LRP5

SNV

Missense_Mutation

rs376914943

c.3220N>A

p.Val1074Ile

p.V1074I

O75197

protein_coding

tolerated(0.25)

possibly_damaging(0.518)

TCGA-BH-A18G-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

LRP5

SNV

Missense_Mutation

c.2242N>T

p.Asp748Tyr

p.D748Y

O75197

protein_coding

deleterious(0)

probably_damaging(0.999)

TCGA-BH-A18L-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Unknown

LRP5

SNV

Missense_Mutation

c.1480N>T

p.Arg494Trp

p.R494W

O75197

protein_coding

deleterious(0)

probably_damaging(0.999)

TCGA-D8-A1JA-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

adriamycin

LRP5

SNV

Missense_Mutation

c.1924N>T

p.Val642Leu

p.V642L

O75197

protein_coding

tolerated(0.09)

benign(0.14)

TCGA-D8-A1XK-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

doxorubicine+cyclophosphamide

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID

Symbol

Category

Interaction Types

Drug Claim Name

Drug Name

PMIDs

Page: 1